Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Synchrony Pharma Ltd., Business Technology Centre, Bessemer Drive, Stevenage, Hertfordshire, SG1 2DX, United Kingdom
Labetalol Synchrony 5mg/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for Injection. The Solution for injection is a clear, colourless liquid, pH 4 (3.5-4.5). Osmolarity 0.03 (0.024-0.036) Osmol/kg. |
Labetalol hydrochloride 5mg/ml. Each 10ml ampoule contains 50mg Labetalol Hydrochloride.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Labetalol |
Labetalol lowers the blood pressure by blocking peripheral arteriolar alphaadrenoceptors thus reducing peripheral resistance, and by concurrent betablockade, protects the heart from reflex sympathetic drive that would otherwise occur. |
| List of Excipients |
|---|
|
Hydrochloric acid (E507) (for pH adjustment) |
Type I amber glass ampoules: 10 ampoules of 10ml (per pack). Ampoules have a white break ring.
Synchrony Pharma Ltd., Business Technology Centre, Bessemer Drive, Stevenage, Hertfordshire, SG1 2DX, United Kingdom
PL 39280/0009
09/05/2018
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
